Biotech · Private company
Acer Therapeutics Inc.
Track this companyFree. Adds Acer Therapeutics Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs4From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline4
- ACER-002 (celiprolol) 200 mg BIDPhase 3 · Vascular Ehlers-Danlos SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- ACER-801 100 mg BIDPhase 2 · Post-menopausal Vasomotor SymptomsClinicalTrials.gov · fetched Nov 12, 2026
- ACER-801 200 mg BIDPhase 2 · Post-menopausal Vasomotor SymptomsClinicalTrials.gov · fetched Nov 12, 2026
- ACER-801 50 mg BIDPhase 2 · Post-menopausal Vasomotor SymptomsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of Sodium Phenylbutyrate (ACER-001) for the Treatment of Patients With Medium Chain Acyl-CoA Dehydrogenase Deficiency (MCADD)PHASE2 · SUSPENDED · started Apr 1, 2024ClinicalTrials.gov NCT06069375 · fetched Nov 12, 2026
- Clinical Trial to Compare the Efficacy of Celiprolol to Placebo in Patients With Vascular Ehlers-Danlos SyndromePHASE3 · RECRUITING · started Nov 7, 2022ClinicalTrials.gov NCT05432466 · fetched Nov 12, 2026
- Dose-ranging, PK, Safety, Efficacy Study of Osanetant in Patients With Moderate/Severe VMS Associated With MenopausePHASE1_PHASE2 · COMPLETED · started Mar 30, 2022ClinicalTrials.gov NCT05325775 · fetched Nov 12, 2026